 |
PDBsum entry 2c8z
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/hydrolase inhibitor
|
PDB id
|
|
|
|
2c8z
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Application of fragment screening and fragment linking to the discovery of novel thrombin inhibitors.
|
 |
|
Authors
|
 |
N.Howard,
C.Abell,
W.Blakemore,
G.Chessari,
M.Congreve,
S.Howard,
H.Jhoti,
C.W.Murray,
L.C.Seavers,
R.L.Van montfort.
|
 |
|
Ref.
|
 |
J Med Chem, 2006,
49,
1346-1355.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
The screening of fragments is an alternative approach to high-throughput
screening for the identification of leads for therapeutic targets. Fragment hits
have been discovered using X-ray crystallographic screening of protein crystals
of the serine protease enzyme thrombin. The fragment library was designed to
avoid any well-precedented, strongly basic functionality. Screening hits
included a novel ligand (3), which binds exclusively to the S2-S4 pocket, in
addition to smaller fragments which bind to the S1 pocket. The structure of
these protein-ligand complexes are presented. A chemistry strategy to link two
such fragments together and to synthesize larger drug-sized compounds resulted
in the efficient identification of hybrid inhibitors with nanomolar potency
(e.g., 7, IC50 = 3.7 nM). These potent ligands occupy the same area of the
active site as previously described peptidic inhibitors, while having very
different chemical architecture.
|
 |
|
|
|
|
 |